Abstract: Provided are a force sensor, a display device including the same, and a method of driving the same. The force sensor includes a first base substrate and a second base substrate facing each other; first force sensor electrodes extending in a first direction and arranged in a second direction crossing the first direction on the first base substrate; second force sensor electrodes extending in the second direction and arranged in the first direction on the second base substrate; and a sensor hole configured to transmit light. Any one of the first force sensor electrodes includes a first sub-force sensor electrode disposed on a first side of the sensor hole and a second sub-force sensor electrode disposed on a second side opposite to the first side of the sensor hole.

Abstract: A pixel may include a first sub-pixel, a third sub-pixel, and a second sub-pixel arranged in a second direction, and each including an emission area and a non-emission area. Each of the first sub-pixel, the second sub-pixel, and the third sub-pixel may include a pixel circuit including at least one transistor and a storage capacitor, a first alignment electrode disposed on the pixel circuit, a second alignment electrode extending spaced apart from the first alignment electrode, a light emitting element disposed between the second alignment electrode and the first alignment electrode, and including a first end adjacent to the second alignment electrode and a second end adjacent to the first alignment electrode, and a bridge pattern spaced apart from the first alignment electrode and the second alignment electrode, and electrically connected to the storage capacitor.

Abstract: A method for inducing reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1 is disclosed. A composition for the prevention or treatment of neurological damage diseases with the neural stem cells induced by the method as an active ingredient is disclosed.

Abstract: The present invention relates to a method for inducing reprogramming of urine cells into keratinocyte stem cells by introducing reprogramming factors Bmi1 and dNP63a, and a composition for promoting skin regeneration which includes an induced reprogrammed keratinocyte stem cell conditioned medium as an active ingredient.